Linked ecologies: States and universities as environments for professions, Sociological theory, vol.23, issue.3, pp.245-274, 2005. ,
Une agence au service d'une stratégie ministérielle. La crise du Mediator et la concordance des champs, Gouvernement et action publique, vol.7, pp.33-55, 2017. ,
Knowledge and valuation in markets, Theory and society, vol.38, issue.2, pp.111-131, 2009. ,
Constructing quality: The classification of goods in markets, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01392957
, The worth of goods: Valuation and pricing in the economy, 2011.
The social order of markets, Theory and society, vol.38, pp.245-269, 2009. ,
Governing by labels? Not that simple: The cases of environmental and nutritional politics in France, Labelling the Economy. Qualities and values in contemporary markets, pp.185-206, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02496702
Monitoring Drug Markets: From Biomedical to Social Valuation. The Case of French Medicines Agency, 2019. ,
Les habits neufs du néo-institutionnalisme? La redécouverte de l'ordre mésologique et de l'agency, L'Année sociologique, vol.66, issue.1, pp.31-72, 2016. ,
Les frontières de l'interdit: le commerce de cannabis, Marchés contestés: quand le marché rencontre la morale, 2015. ,
Towards a Sociology of the Boundary-Entrepreneur, Revue française de sociologie, vol.54, pp.263-302, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01719501
Enrichissement. Une critique de la marchandise, 2017. ,
, On justification: Economies of worth, vol.27, 2006.
Les structures sociales de l'économie, 2000. ,
Sorting things out: Classification and its consequences, 2000. ,
Reputation and power: organizational image and pharmaceutical regulation at the FDA, vol.137, 2014. ,
At the boundaries of food and medicine: the genesis and transformation of the "functional food" markets in France and Europe, LIEPP Working Paper, vol.90, pp.1-21, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02290956
Architecture des prix et morphologie sociale du marché, Revue française de sociologie, vol.52, pp.277-309, 2011. ,
The sociology of market work, Economic Sociology_the European Electronic Newsletter, vol.15, issue.1, pp.4-11, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01522875
The political economy of HIV/AIDS in developing countries: TRIPS, public health systems and free access, 2008. ,
International encyclopedia of unified science 2, 4, vii + 67, 1939. ,
Que vaut une molécule? Formulation de la valeur dans les projets de développement de nouveaux médicaments, Revue d'anthropologie des connaissances, vol.9, pp.17-38, 2015. ,
Forging industrial policy: The United States, Britain, and France in the railway age, 1994. ,
, Gouverner les conduites. Paris: Presses de Sciences Po, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01354197
Value practices in the life sciences and medicine, 2015. ,
Commensuration as a social process, Annual review of sociology, vol.24, issue.1, pp.313-343, 1998. ,
Les figures urbaines de la santé publique enquêtes sur des expériences locales, 1998. ,
The architecture of markets: An economic sociology of twenty-first-century capitalist societies, 2002. ,
Le pouvoir et la règle. Dynamiques de l'action organisée, 1993. ,
The Rise (and Fall) of the Food-Drug Line: Classification, Gatekeepers, and Spatial Mediation in Regulating U.S. Food and Health Markets, Risk on the Table: Food, Health, and Environmental Exposure, 2020. ,
Boundary-work and the demarcation of science from non-science: Strains and interests in professional ideologies of scientists, American sociological review, vol.48, pp.781-795, 1983. ,
Generic: The unbranding of modern medicine, 2014. ,
Prescribing by numbers: drugs and the definition of disease, 2006. ,
L'Europe du médicament: politique-expertise-intérêts privés, Presses de Sciences Po, 2005. ,
For what it's worth: An introduction to valuation studies, Valuation Studies, vol.1, issue.1, pp.1-10, 2013. ,
The economics of singularities, 2010. ,
Markets on trial: The economic sociology of the US financial crisis, 2010. ,
The new European agencies: regulation by information, Journal of European Public Policy, vol.4, issue.2, pp.262-275, 1997. ,
Financialization and productive models in the pharmaceutical industry, Industrial and Corporate Change, vol.22, issue.4, pp.981-1030, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-02425108
A flank movement in the understanding of valuation, The Sociological Review, vol.59, pp.24-38, 2011. ,
URL : https://hal.archives-ouvertes.fr/halshs-00706766
Des médicaments à tout prix: sociologie des génériques en France, Presses de Sciences Po, 2017. ,
Governing (through) Prices Determining the Price of Reimbursed Pharmaceuticals in France, Revue française de sociologie, vol.58, issue.3, pp.399-424, 2017. ,
Governing the market through prices: The state and controls on the price of medicines in France, Economic Sociology_the European Electronic Newsletter, vol.15, issue.2, pp.41-48, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01025154
Impostures pharmaceutiques: médicaments illicites et luttes pour l'accès à la santé, 2018. ,
The sense of dissonance: Accounts of worth in economic life, 2011. ,
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha, Chicago Journal of International Law, vol.3, issue.1, pp.27-46, 2002. ,
Valuation as evaluating and valorizing, Valuation Studies, vol.1, issue.1, pp.31-50, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01154593
Évaluer et valoriser: une sociologie économique de la mesure, 2009. ,
Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study, The Lancet Oncology, vol.17, issue.1, pp.39-47, 2016. ,
Economic lives: How culture shapes the economy, 2013. ,